DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy

MLA

Tawk, B., et al. “DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.” Clinical Cancer Research 29(2023)16, 3051-3064, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1427182396&authtype=sso&custid=ns315887.

APA

Tawk, B., Rein, K., Schwager, C., Knoll, M., Wirkner, U., Hörner-Rieber, J., Liermann, J., Kurth, I., Balermpas, P., Rödel, C., Linge, A., Löck, S., Lohaus, F., Tinhofer, I., 0000-0003-1776-9556) Krause, M., Stuschke, M., Ligia Grosu, A., Zips, D., Combs, S. E., … Abdollahi, A. (2023). DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy. Clinical Cancer Research 29(2023)16, 3051-3064.

Chicago

Tawk, B., K. Rein, C. Schwager, M. Knoll, U. Wirkner, J. Hörner-Rieber, J. Liermann, et al. 2023. “DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.” Clinical Cancer Research 29(2023)16, 3051-3064. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1427182396&authtype=sso&custid=ns315887.